X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
febuxostat (215) 215
gout (141) 141
humans (135) 135
hyperuricemia (127) 127
index medicus (127) 127
allopurinol (122) 122
male (85) 85
pharmacology & pharmacy (85) 85
uric acid (77) 77
pharmacokinetics (66) 66
gout - drug therapy (65) 65
female (62) 62
uric acid - blood (57) 57
gout suppressants - therapeutic use (55) 55
xanthine oxidase - antagonists & inhibitors (54) 54
adult (53) 53
hyperuricemia - drug therapy (53) 53
middle aged (53) 53
management (52) 52
rheumatology (46) 46
aged (42) 42
pharmacodynamics (39) 39
treatment outcome (39) 39
gout suppressants - adverse effects (37) 37
serum urate (36) 36
gout suppressants - administration & dosage (33) 33
rheumatism (33) 33
safety (33) 33
thiazoles - therapeutic use (33) 33
xanthine-oxidase (33) 33
urate (31) 31
double-blind (29) 29
drug therapy (28) 28
thiazoles - pharmacokinetics (28) 28
uric-acid (28) 28
medicine & public health (27) 27
animals (26) 26
care and treatment (26) 26
febuxostat - therapeutic use (26) 26
arthritis (25) 25
analysis (24) 24
oxidases (24) 24
thiazoles - adverse effects (24) 24
allopurinol - therapeutic use (23) 23
chronic kidney disease (23) 23
gout suppressants - pharmacokinetics (23) 23
xanthine oxidase (23) 23
drug dosages (22) 22
double-blind method (21) 21
efficacy (21) 21
gout - blood (21) 21
non-purine (21) 21
nonpurine selective inhibitor (21) 21
thiazoles - administration & dosage (21) 21
thiazoles - pharmacology (21) 21
iron compounds (20) 20
research (19) 19
young adult (19) 19
dose-response relationship, drug (18) 18
febuxostat - administration & dosage (18) 18
gout suppressants - pharmacology (18) 18
lesinurad (18) 18
administration, oral (17) 17
enzyme inhibitors - pharmacology (17) 17
xanthine oxidase inhibitor (17) 17
molybdenum compounds (16) 16
patients (16) 16
pharmacology (16) 16
selective inhibitor (16) 16
urate-lowering therapy (16) 16
benzbromarone (15) 15
clinical trials (15) 15
drug interactions (15) 15
risk (15) 15
uric acid - metabolism (15) 15
area under curve (14) 14
chemistry, analytical (14) 14
hyperuricemia - blood (14) 14
purines (14) 14
research article (14) 14
therapy (14) 14
tmx-67 (14) 14
xanthine oxidase - metabolism (14) 14
abridged index medicus (13) 13
aged, 80 and over (13) 13
biochemistry & molecular biology (13) 13
chemistry, medicinal (13) 13
chronic kidney failure (13) 13
colchicine (13) 13
enzyme inhibitors - therapeutic use (13) 13
febuxostat - pharmacokinetics (13) 13
inhibitor (13) 13
mass spectrometry (13) 13
pharmacology/toxicology (13) 13
renal-function (13) 13
serum uric-acid (13) 13
thiazoles - blood (13) 13
urine (13) 13
xanthine (13) 13
adolescent (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 10/2018, Volume 84, Issue 10, pp. 2260 - 2269
Aim Febuxostat is an active xanthine oxidase (XO) inhibitor which is widely used in the treatment of hyperuricaemia. We aimed to evaluate the predictive... 
chronic kidney disease | febuxostat | pharmacometrics | hyperuricaemia | SERUM URATE | OXYPURINOL | MANAGEMENT | GOUT | AMERICAN-COLLEGE | EXCRETION | ALLOPURINOL | XANTHINE-OXIDASE | DISEASE | PHARMACOLOGY & PHARMACY | URIC-ACID | Oxidases | Medical records | Diuretics | Medical colleges | Chronic kidney failure | Analysis | Original
Journal Article
Journal Article
Journal Article
Rheumatology (Oxford, England), ISSN 1462-0324, 12/2014, Volume 53, Issue 12, pp. 2167 - 2174
Journal Article
Clinical Pharmacology in Drug Development, ISSN 2160-763X, 02/2019, Volume 8, Issue 2, pp. 179 - 187
Verinurad (RDEA3170) is a selective uric acid reabsorption inhibitor in development for treatment of gout and asymptomatic hyperuricemia. This phase 1,... 
pharmacokinetics | verinurad | febuxostat | pharmacodynamics | gout | MANAGEMENT | GOUT PATIENTS | EVIDENCE-BASED RECOMMENDATIONS | XANTHINE-OXIDASE | LESINURAD | HYPERURICEMIA | ACID REABSORPTION INHIBITOR | PURINE SELECTIVE INHIBITOR | PHARMACOLOGY & PHARMACY | QUALITY-OF-LIFE | CARE UTILIZATION | Original Manuscript
Journal Article